Tue-08-03-2016, 07:58 AM
Certainly for the people with Crohns this is very important. There is currently not much to give an answer to treat Crohns.
AbbVie and Boehringer Ingelheim to develop and commercialize BI 655066
|
« Next Oldest | Next Newest »
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
Obese children more likely to develop psoriasis | Fred | 2 | 754 |
Thu-22-08-2024, 19:53 PM Last Post: Fred |
|
AbbVie will present data on risankizumab at EADV | Fred | 3 | 5,628 |
Mon-26-09-2016, 17:07 PM Last Post: jiml |
|
Psoriasis clear 66 months after one subcutaneous injection of trial drug BI 655066 | Fred | 11 | 16,271 |
Tue-08-03-2016, 19:10 PM Last Post: D Foster |
|
New psoriasis treatment BI 655066 worked faster than Stelara | Fred | 3 | 5,124 |
Thu-08-10-2015, 13:48 PM Last Post: jiml |
|
Queen Mary University to develop a targeted approach to psoriasis treatment | Fred | 18 | 26,289 |
Sat-30-11-2013, 12:05 PM Last Post: jiml |